[
    {
        "drugresponse_id": "10305",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H720",
        "VALUE": "4.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1583",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Carcinoid Tumor",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10306",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H1648",
        "VALUE": "3.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1482",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10307",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H1650",
        "VALUE": "4.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1483",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Bronchiolo-Alveolar Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10308",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H1770",
        "VALUE": "4.56",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1493",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Non-Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10309",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H1838",
        "VALUE": "3.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1499",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10310",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "DMS-114",
        "VALUE": "3.77",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1174",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10311",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H1092",
        "VALUE": "3.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1454",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10312",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H1694",
        "VALUE": "3.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1489",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10313",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H187",
        "VALUE": "4.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1501",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10314",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H1963",
        "VALUE": "4.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1510",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10315",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H209",
        "VALUE": "5.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1525",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10316",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H2141",
        "VALUE": "3.56",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1534",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10317",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H2171",
        "VALUE": "4.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1536",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10318",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H2227",
        "VALUE": "3.72",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1542",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10319",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H345",
        "VALUE": "3.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1558",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10320",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H446",
        "VALUE": "4.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1562",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10321",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H526",
        "VALUE": "5.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1569",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10322",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H64",
        "VALUE": "4.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1573",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10323",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H69",
        "VALUE": "4.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1579",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10324",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H82",
        "VALUE": "5.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1591",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10328",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "LU-139",
        "VALUE": "4.96",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1390",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10329",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "SBC-1",
        "VALUE": "3.83",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1676",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10330",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H1299",
        "VALUE": "4.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0060",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Large Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10331",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "Calu-6",
        "VALUE": "4.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0236",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10332",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "LU-65",
        "VALUE": "4.7",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1392",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Giant Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10333",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H1355",
        "VALUE": "3.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1464",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10334",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "SHP-77",
        "VALUE": "4.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1693",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10336",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "HCC1187",
        "VALUE": "4.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1247",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10337",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "HCC1599",
        "VALUE": "4.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1256",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10338",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "HCC2157",
        "VALUE": "4.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1261",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10339",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "HCC2218",
        "VALUE": "3.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1263",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10344",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "CPC-N",
        "VALUE": "4.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1146",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10347",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "DMS-79",
        "VALUE": "4.21",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1178",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10352",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "IST-SL1",
        "VALUE": "4.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1313",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10353",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "IST-SL2",
        "VALUE": "4.56",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1314",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10358",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "LB647-SCLC",
        "VALUE": "4.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1368",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10362",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "LU-134-A",
        "VALUE": "4.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1387",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10363",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "LU-165",
        "VALUE": "4.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1391",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10364",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "LXF-289",
        "VALUE": "3.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1394",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10368",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H128",
        "VALUE": "4.16",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1460",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10369",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H1304",
        "VALUE": "4.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1462",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10370",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H510A",
        "VALUE": "3.91",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1565",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10382",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H226",
        "VALUE": "3.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1544",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Pleural Epithelioid Mesothelioma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10383",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H23",
        "VALUE": "5.21",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1547",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10390",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H322M",
        "VALUE": "3.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1557",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Bronchiolo-Alveolar Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10391",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "EKVX",
        "VALUE": "3.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1195",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10393",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "HOP-62",
        "VALUE": "4.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1285",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10402",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "OVCAR-4",
        "VALUE": "5.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1627",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "High Grade Ovarian Serous Adenocarcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10409",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "COR-L88",
        "VALUE": "4.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1141",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10410",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "COLO-824",
        "VALUE": "3.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1136",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10419",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "DU-4475",
        "VALUE": "5.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1183",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10425",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "EVSA-T",
        "VALUE": "3.72",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1207",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10441",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "IST-MES1",
        "VALUE": "3.77",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1311",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Pleural Epithelioid Mesothelioma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10465",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "LC-2-ad",
        "VALUE": "4.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1373",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10484",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "MPP-89",
        "VALUE": "3.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1427",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Pleural Epithelioid Mesothelioma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10485",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "MRK-nu-1",
        "VALUE": "3.87",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1428",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10486",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "MSTO-211H",
        "VALUE": "5.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1430",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Pleural Biphasic Mesothelioma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10504",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H1155",
        "VALUE": "4.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1456",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Large Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10505",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H1436",
        "VALUE": "3.45",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1471",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10506",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H1581",
        "VALUE": "3.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1479",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Large Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10507",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H1666",
        "VALUE": "4.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1485",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Bronchiolo-Alveolar Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10508",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H2081",
        "VALUE": "3.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1522",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10509",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H2196",
        "VALUE": "4.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1539",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10510",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H524",
        "VALUE": "4.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1568",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10511",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H748",
        "VALUE": "4.62",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1588",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10517",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "OCUB-M",
        "VALUE": "3.84",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10547",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "KURAMOCHI",
        "VALUE": "4.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1345",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "High Grade Ovarian Serous Adenocarcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10560",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "COLO-668",
        "VALUE": "4.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1128",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10571",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "UACC-812",
        "VALUE": "3.86",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1781",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Invasive Ductal Carcinoma Not Otherwise Specified",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10583",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "MFM-223",
        "VALUE": "3.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1408",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10585",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "CAL-148",
        "VALUE": "3.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1106",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10587",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "KGN",
        "VALUE": "4.45",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0375",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "Ovarian Granulosa Cell Tumor",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10591",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H1975",
        "VALUE": "4.87",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1511",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10602",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "BT-474",
        "VALUE": "3.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0179",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Invasive Ductal Carcinoma Not Otherwise Specified",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10636",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "ES-2",
        "VALUE": "5.72",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3509",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "Ovarian Clear Cell Adenocarcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10640",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H1836",
        "VALUE": "4.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1498",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10641",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H1869",
        "VALUE": "3.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1500",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Non-Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10642",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H211",
        "VALUE": "4.78",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1529",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10643",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H847",
        "VALUE": "4.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1596",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10650",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "COR-L95",
        "VALUE": "4.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2418",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10654",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H2135",
        "VALUE": "3.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1533",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Non-Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10658",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "HCC1500",
        "VALUE": "4.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1254",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10659",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "HCC-33",
        "VALUE": "4.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2058",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "10673",
        "COMPOUND_NAME": "Pyrimethamine",
        "CELL_LINE_NAME": "NCI-H1876",
        "VALUE": "4.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "4993.0",
        "CHEMBL_ID": "CHEMBL36",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1503",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "WKSAUQYGYAYLPV-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "3"
    },
    {
        "drugresponse_id": "5149",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H720",
        "VALUE": "4.89",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1583",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Carcinoid Tumor",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5150",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1648",
        "VALUE": "6.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1482",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5151",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1770",
        "VALUE": "4.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1493",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Non-Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5152",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1838",
        "VALUE": "4.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1499",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5153",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "DMS-114",
        "VALUE": "4.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1174",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5154",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1092",
        "VALUE": "4.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1454",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5155",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1694",
        "VALUE": "5.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1489",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5156",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H187",
        "VALUE": "4.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1501",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5157",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1963",
        "VALUE": "4.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1510",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5158",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H209",
        "VALUE": "4.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1525",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5159",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H2141",
        "VALUE": "4.77",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1534",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5160",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H2171",
        "VALUE": "5.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1536",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5161",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H345",
        "VALUE": "4.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1558",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5162",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H446",
        "VALUE": "4.91",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1562",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5163",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H526",
        "VALUE": "4.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1569",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5164",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H64",
        "VALUE": "5.02",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1573",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5165",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H69",
        "VALUE": "4.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1579",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5166",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H82",
        "VALUE": "4.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1591",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5170",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LU-139",
        "VALUE": "4.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1390",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5171",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SBC-1",
        "VALUE": "4.62",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1676",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5172",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1299",
        "VALUE": "5.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0060",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Large Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5173",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "Calu-6",
        "VALUE": "4.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0236",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5174",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LU-65",
        "VALUE": "4.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1392",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Giant Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5175",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1355",
        "VALUE": "5.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1464",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5176",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SHP-77",
        "VALUE": "5.16",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1693",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5178",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "HCC1187",
        "VALUE": "4.86",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1247",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5179",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "HCC1599",
        "VALUE": "5.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1256",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5180",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "HCC2157",
        "VALUE": "4.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1261",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5181",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "HCC2218",
        "VALUE": "4.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1263",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5186",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "CPC-N",
        "VALUE": "4.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1146",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5188",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "DMS-79",
        "VALUE": "4.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1178",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5194",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "IST-SL1",
        "VALUE": "4.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1313",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5195",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "IST-SL2",
        "VALUE": "5.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1314",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5200",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LB647-SCLC",
        "VALUE": "4.89",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1368",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5204",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LU-134-A",
        "VALUE": "4.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1387",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5205",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LU-165",
        "VALUE": "4.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1391",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5206",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LXF-289",
        "VALUE": "5.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1394",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5210",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H128",
        "VALUE": "4.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1460",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5211",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1304",
        "VALUE": "4.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1462",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5212",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H510A",
        "VALUE": "5.29",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1565",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5224",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H226",
        "VALUE": "4.77",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1544",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Pleural Epithelioid Mesothelioma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5225",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H23",
        "VALUE": "4.64",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1547",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5232",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H322M",
        "VALUE": "3.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1557",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Bronchiolo-Alveolar Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5233",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EKVX",
        "VALUE": "4.78",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1195",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5234",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "HOP-62",
        "VALUE": "5.72",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1285",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5243",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "OVCAR-4",
        "VALUE": "5.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1627",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "High Grade Ovarian Serous Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5250",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "COR-L88",
        "VALUE": "4.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1141",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5251",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "COLO-824",
        "VALUE": "4.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1136",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5260",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "DU-4475",
        "VALUE": "4.66",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1183",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5267",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "EVSA-T",
        "VALUE": "5.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1207",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5283",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "IST-MES1",
        "VALUE": "5.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1311",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Pleural Epithelioid Mesothelioma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5307",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LC-2-ad",
        "VALUE": "5.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1373",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5326",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "MPP-89",
        "VALUE": "5.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1427",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Pleural Epithelioid Mesothelioma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5327",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "MRK-nu-1",
        "VALUE": "4.69",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1428",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5328",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "MSTO-211H",
        "VALUE": "5.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1430",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Pleural Biphasic Mesothelioma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5346",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1155",
        "VALUE": "4.72",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1456",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Large Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5347",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1436",
        "VALUE": "6.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1471",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5348",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1581",
        "VALUE": "4.72",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1479",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Large Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5349",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1666",
        "VALUE": "4.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1485",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Bronchiolo-Alveolar Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5350",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H2081",
        "VALUE": "4.45",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1522",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5351",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H2196",
        "VALUE": "4.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1539",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5352",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H524",
        "VALUE": "5.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1568",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5353",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H748",
        "VALUE": "4.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1588",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5359",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "OCUB-M",
        "VALUE": "5.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5390",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "KURAMOCHI",
        "VALUE": "5.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1345",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "High Grade Ovarian Serous Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5403",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "COLO-668",
        "VALUE": "4.52",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1128",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5411",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "IA-LM",
        "VALUE": "4.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1302",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Large Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5416",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "UACC-812",
        "VALUE": "5.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1781",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Invasive Ductal Carcinoma Not Otherwise Specified",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5431",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "MFM-223",
        "VALUE": "4.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1408",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5433",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "CAL-148",
        "VALUE": "4.78",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1106",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5435",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "KGN",
        "VALUE": "6.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0375",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "Ovarian Granulosa Cell Tumor",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5441",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1975",
        "VALUE": "5.61",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1511",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5453",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "BT-474",
        "VALUE": "4.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0179",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Invasive Ductal Carcinoma Not Otherwise Specified",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5486",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "ES-2",
        "VALUE": "5.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_3509",
        "ONCOTREE_LINEAGE": "Ovary",
        "ONCOTREE_PRIMARY_DISEASE": "Ovarian Clear Cell Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5490",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1836",
        "VALUE": "4.76",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1498",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5491",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1869",
        "VALUE": "5.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1500",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Non-Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5492",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H211",
        "VALUE": "5.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1529",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5493",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H847",
        "VALUE": "4.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1596",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5500",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "COR-L95",
        "VALUE": "4.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2418",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5504",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H2135",
        "VALUE": "4.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1533",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Non-Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5508",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "HCC1500",
        "VALUE": "4.62",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1254",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5509",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "HCC-33",
        "VALUE": "4.7",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_2058",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5526",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1876",
        "VALUE": "4.63",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1503",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5149",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H720",
        "VALUE": "4.89",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1583",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Carcinoid Tumor",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5150",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1648",
        "VALUE": "6.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1482",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5151",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1770",
        "VALUE": "4.67",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1493",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Non-Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5152",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1838",
        "VALUE": "4.47",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1499",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5153",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "DMS-114",
        "VALUE": "4.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1174",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5154",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1092",
        "VALUE": "4.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1454",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5155",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1694",
        "VALUE": "5.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1489",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5156",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H187",
        "VALUE": "4.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1501",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5157",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1963",
        "VALUE": "4.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1510",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5158",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H209",
        "VALUE": "4.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1525",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5159",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H2141",
        "VALUE": "4.77",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1534",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5160",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H2171",
        "VALUE": "5.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1536",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5161",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H345",
        "VALUE": "4.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1558",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5162",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H446",
        "VALUE": "4.91",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1562",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5163",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H526",
        "VALUE": "4.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1569",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5164",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H64",
        "VALUE": "5.02",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1573",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5165",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H69",
        "VALUE": "4.74",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1579",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5166",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H82",
        "VALUE": "4.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1591",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5170",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LU-139",
        "VALUE": "4.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1390",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5171",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SBC-1",
        "VALUE": "4.62",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1676",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5172",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1299",
        "VALUE": "5.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0060",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Large Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5173",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "Calu-6",
        "VALUE": "4.88",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_0236",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5174",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "LU-65",
        "VALUE": "4.51",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1392",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Giant Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5175",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "NCI-H1355",
        "VALUE": "5.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1464",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Lung Adenocarcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5176",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "SHP-77",
        "VALUE": "5.16",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1693",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5178",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "HCC1187",
        "VALUE": "4.86",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1247",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5179",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "HCC1599",
        "VALUE": "5.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1256",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5180",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "HCC2157",
        "VALUE": "4.65",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1261",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5181",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "HCC2218",
        "VALUE": "4.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1263",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5186",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "CPC-N",
        "VALUE": "4.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1146",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5188",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "DMS-79",
        "VALUE": "4.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1178",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5194",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "IST-SL1",
        "VALUE": "4.82",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1313",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    },
    {
        "drugresponse_id": "5195",
        "COMPOUND_NAME": "Saracatinib",
        "CELL_LINE_NAME": "IST-SL2",
        "VALUE": "5.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "-1.0",
        "CHEMBL_ID": "CHEMBL217092",
        "MAX_PHASE": "Phase III",
        "RRID": "CVCL_1314",
        "ONCOTREE_LINEAGE": "Lung",
        "ONCOTREE_PRIMARY_DISEASE": "Small Cell Lung Carcinoma",
        "INCHI_KEY": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Alcohol Consumption",
        "Phase": "2"
    }
]